Find the countries worth a closer look

British Columbia's Family Law Act contains a province-specific parentage rule for a surrogacy arrangement, including post-birth conditions; it must not be generalized to other provinces.

Health Canada guidance describes categories and documentation for eligible reimbursements and requires that reimbursement not produce monetary gain. No synthetic journey total is inferred.

Provider-published full-journey range: CAD 41,600–108,000. The source includes a CAD 10,000–20,000 frozen-transfer/IVF line, so an IVF-excluded total is not separable and must not be treated as a quote.

Constitutional Court Decision T-127/24 is retained as court evidence of a regulatory vacuum and case-specific parentage concerns, not as a complete administrative pathway.

A Medellín provider publishes USD 5,000–8,000 for standard IVF with medication. The cited scope includes consultation, monitoring, retrieval, fertilization, fresh transfer, and stimulation medication; clinic-specific confirmation is required.

What current citizenship, residence, relationship, medical, and genetic-link conditions govern access after all enacted amendments?

The reviewed Georgian exit-law source addresses departure of a child born through surrogacy and makes the Georgian birth record part of the exit analysis; citizenship and home-country recognition remain separate.

A provider publishes a USD 76,000 package for intended parents with existing embryos. Travel, documents, PGT, complications, extra attempts, and home-country work may be additional.

A provider lists USD 4,800 for IVF/ICSI plus ovarian-stimulation medication. PGT, storage, donor services, and repeat cycles may add cost.

The current Russian official text reflects 2026 amendments stating that customers under a surrogacy agreement are Kazakhstan citizens in a registered marriage; the English consolidation and transitional treatment require a separate translation and specialist check.

Kazakhstan's reviewed family-code framework links the notarized surrogacy contract to legal consequences and intended-parent registration, subject to current eligibility, implementation, and document-chain checks.

Kazakhstan's code places specified pregnancy, delivery, and post-delivery expenses within the notarized contract framework. The source does not supply a universal market total.

Which jurisdictions use pre-transfer, pre-birth, post-birth, amparo, recognition, or adoption procedures for each family configuration?

A provider publishes USD 52,800 for a full-service program using existing embryos. Embryo import, shipping, state-specific legal work, travel, and contingencies may be additional.

A provider publishes USD 4,500–7,500 from basic IVF to IVF/ICSI. Medication, PGT, donors, freezing, storage, and repeat cycles may add cost.

Thai Health Service Support guidance describes an authorized gestational-surrogacy route for a legally married husband and wife when the wife has a medical indication preventing pregnancy; it also states that certified assisted-reproduction facilities and authorization are required.

One Bangkok hospital lists THB 335,000–456,000 from standard IVF to a package with PGT and embryo freezing. This IVF signal does not establish access to a surrogacy route.

What current eligibility conditions, genetic-link rules, and medical indications apply under the consolidated law and Order No. 787?

Article 123 of the Family Code addresses parentage when an embryo conceived by spouses through assisted reproductive technology is transferred to another woman, but the exact current eligibility and document chain must be read with medical and registration rules.

A provider publishes USD 22,600–23,300 for a frozen-embryo program. Egg retrieval and embryo creation are outside the listed program; safety, travel, legal, war-risk, and contingency costs require separate review.

New York's Child-Parent Security Act took effect on February 15, 2021 and created a state framework for gestational-surrogacy agreements, surrogate protections, parentage, and licensing of gestational-surrogacy organizations.

Provider-published full-service agency planning range: USD 190,000–240,000. Inclusions differ materially; some exclude intended-parent IVF and egg-donor costs. This is a market signal, not a quote or synthetic total.

One clinic lists UZS 31,000,000–38,440,000 for IVF/ICSI; the upper figure reflects the listed non-resident uplift and freezing-inclusive scope. ART pricing does not establish a surrogacy pathway.